Healthcare Investing in the Post COVID-19 Era: Implications for Value Creation in Private Equity

The COVID-19 crisis has been accelerating change we already knew we needed to make in healthcare: shift to telemedicine and telehealth, remote clinical trials, shortened lab-to-market timelines for vaccines and drugs.

About this program

The COVID-19 crisis has been accelerating change we already knew we needed to make in healthcare:  shift to telemedicine and telehealth, remote clinical trials, shortened lab-to-market timelines for vaccines and drugs. What will this mean for Private Equity Investors and how are they thinking about value creation given the current disruption in the marketplace?  As part of this webinar, we will look to explore what are some of the opportunities that are emerging for PE in healthcare.

Want to get involved or join the program?